Abstract: The present invention relates to compositions and methods for the prevention and/or treatment of allergic, autoimmune, septic shock or infectious diseases using magnesium gluconate alone or in combination with one or more antioxidants or an antiinflammatory agent. The invention also relates to the inhibition of production of inappropriate levels of lipid mediators and cytokines.
Type:
Grant
Filed:
April 23, 1997
Date of Patent:
August 17, 1999
Assignee:
Fleming & Company
Inventors:
Thomas E. Fleming, Herbert C. Mansmann, Jr.
Abstract: The present invention relates to methods and compositions for the prevention and/or treatment of exercise-induced muscle cramps, stiffness, pain or spasms, using magnesium gluconate alone or in combination with one or more antioxidants or conventional pharmacologic therapy. The invention also relates to inhibition of production of oxygenated molecules, oxygen free radicals and lipid peroxidation.
Type:
Grant
Filed:
April 23, 1997
Date of Patent:
July 13, 1999
Assignee:
Fleming & Company, Pharmaceuticals
Inventors:
Thomas E. Fleming, Herbert C. Mansmann, Jr.
Abstract: The present invention relates to methods and compositions for the prevention and/or treatment of diabetes mellitus, using magnesium gluconate alone or in combination with one or more antioxidants or conventional diet and/or insulin therapy. The invention also relates to inhibition of production of oxygen free radicals and lipid peroxidation.
Type:
Grant
Filed:
April 23, 1997
Date of Patent:
February 16, 1999
Assignee:
Fleming & Company, Pharmaceuticals
Inventors:
Thomas E. Fleming, Herbert C. Mansmann, Jr.